(Q34617633)

English

Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

author name string

Anita K Gandhi

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Derek Mendy

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michelle Waldman

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Gengxin Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Emily Rychak

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Karen Miller

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Svetlana Gaidarova

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yan Ren

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Maria Wang

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michael Breider

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Gilles Carmel

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Afshin Mahmoudi

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Pilgrim Jackson

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mahan Abbasian

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Brian E Cathers

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Peter H Schafer

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tom O Daniel

17

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Antonia Lopez-Girona

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Anjan Thakurta

19

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Rajesh Chopra

20

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

28 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

164

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

233-244

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Genome-wide association study of antibody response to smallpox vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Initial genome sequencing and analysis of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Identification of a primary target of thalidomide teratogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

7 July 2018

High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

26 October 2018

High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

26 October 2018

BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253085

26 October 2018

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24206017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24206017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/BJH.12622

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34617633&oldid=1633529640"